Parathyroid hormone related protein (PTHrP) inhibits TNFα-induced apoptosis by blocking the extrinsic and intrinsic pathways

Journal of Cellular Physiology

Volumn 210, Issue 2, 2007, Pages 507-516

  Okoumassoun, Liliane ^a   Averill Bates, Diana ^b   Denizeau, Francine ^b   Henderson, Janet E ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; MUTANT PROTEIN; PARATHYROID HORMONE RELATED PROTEIN; PROTEIN; PROTEIN BCL 2; PROTEIN BID; PROTEIN M1PTHRP; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; BIOGENESIS; CELL DEATH; CELL NUCLEUS; CELL PROLIFERATION; CELL PROTECTION; CELL STRAIN; CELL SURVIVAL; CONTROLLED STUDY; CYTOSOL; EMBRYO; ENZYME RELEASE; FUNCTIONAL PROTEOMICS; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; RIBOSOME; SIGNAL TRANSDUCTION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CASPASE 8; CELLS, CULTURED; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOCHONDRIAL MEMBRANES; MUTATION; PARATHYROID HORMONE-RELATED PROTEIN; RECEPTORS, DEATH DOMAIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33845644670     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20892     Document Type: Article

References (61)

1. Aarts M, Guo R, Bringhurst R, Henderson JE. 1999a. The Nucleolar Targeting Signal (NTS) of parathyroid hormone related protein (PTHrP) mediate endocytosis and nuclear translocation. J Bone Miner Res 14:1493-1503.
2. Aarts MM, Levy D, He B, Stregger S, Chen T, Richard S, Henderson JE. 1999b. Parathyroid hormone related protein (PTHrP) interacts with RNA. J Biol Chem 274:4832-4838.
3. Aarts M, Davidson D, Corluka A, Petroulakis E, Guo J, Bringhurst F, Galipeau J, Henderson J. 2001. PTHrP promotes quiescence and survival of serum deprived chondrocytes by inhibiting rRNA synthesis. J Biol Chem 276:37934-37943.
4. Amizuka N, Karaplis AC, Henderson JE, Warshawsky H, Lipman ML, Matsuki Y, Ejiri S, Tanaka M, Izumi N, Ozawa H et al. 1995. Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal post-natal bone development. Dev Biol 175:166-176.
5. Amizuka N, Henderson JE, Hoshi K, Warshawsky H, Ozawa H, Goltzman D, Karaplis AC. 1996. Programmed cell death of chondrocytes and aberrant chondrogenesis in mice homozygous for parathyroid hormone-related peptide gene deletion. Endocrinology 137:5055-5067.
6. Amizuka N, Davidson D, Liu H, Valverde-Franco G, Chai S, Sasaki T, Ozawa H, Hammond V, Ornitz DM, Goltzman D et al. 2003. Signaling by fibroblast growth factor receptor 3 (FGFR3) and parathyroid hormone related protein (PTHrP) coordinate cartilage and bone development. Bone 34:13-25.
7. Arming M, Neff L, Tanaka S, Inoue D, Kuida K, Weir E, Philbrick WM, Broadus AE, Baron R, 1997. Bcl-2 lies downstream of parathyroid hormone-related peptide in a signaling pathway that regulates chondrocyte maturation during skeletal development. J Cell Biol 136:205-213.
8. Anderson P, Phillips K, Stoecklin G, Kedersha N. 2004. Post-transcriptional regulation of proinflammatory proteins. J Leuk Biol 76:42-47.
9. Antonsson B, Martinou JC. 2000. The Bcl-2 protein family. Exptl Cell Res 256:50-57.
10. Beem E, Holliday LS, Segal MS. 2004. The 1.4-MDa apoptosome is a critical intermediate in apoptosome maturation. Am J Physiol-Cell Physiol 287:C664-C672.
11. Bringhurst FR, Strewler GJ. 2002. Renal and skeletal actions of parathyroid hormone (PTH) and PTH-related protein. In: Bilezekian JP, Raisz LG, Rodan GA, editors. Principles of Bone Biology. Second edition. New York: Academic Press, pp 483-514.
12. Cebrian A, Garcia-Ocana A, Takane KK, Sipulda D, Stewart AF, Vasavada RC. 2002. Overexpression of parathyroid hormone-related protein inhibits pancreatic beta-cell death in vivo and in vitro. Diabetes 51:303-313.
13. Chandra D, Choy G, Daniel PT, Tang DG. 2005. Bax-dependent regulation of Bak by voltage-dependent anion channel 2. J Biol Chem 280:19051-19061.
14. Chang YC, Xu YH. 2000. Expression of Bcl-2 inhibited Fas-mediated apoptosis in human hepatocellular carcinoma BEL-7404 cells. Cell Res 10:233-242.
15. Cheng EHY, Sheiko TV, Fisher JK, Craigen WJ, Korsemyer SJ. 2003. VDAC inhibits Bak activation and mitochondrial apoptosis. Science 301:513-517.
16. Davidson D, Blanc A, Filion D, Wang H, Plut P, Pfeffer G, Buschmann MD, Henderson JE. 2005. FGF18 signals through FGFR3 to promote chondrogenesis. J Biol Chem 280:20509-20515.
17. Deng Y, Lin Y, Wu X. 2002. TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO. Genes Dev 16:33-45.
18. Goldring SR, Goldring MB. 2004. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Orthop Rel Res 427:S27-S36.
19. Guo J, Lanske B, Liu BY, Divieti P, Kronenberg HM, Bringhurst FR. 2001. Signal selectivity of parathyroid hormone (PTH) PTH-related peptide receptor mediated regulation of differentiation in conditionally immortalized growth plate chondrocytes. Endocrinology 142:1260-1268.
20. Gustafsson AB, Tsai JG, Logue SE, Crow MT, Gottlieb RA. 2004. Apoptosis repressor with caspase recruitment domain protects against cell death by interfering with Bax activation. J Biol Chem 279:21233-21238.
21. Hastings R, Summers-Torres D, Burton D, Deftos L. 1997. Growth factor control of type II cell apoptosis. Chest 116:68S.
22. Henderson JE, Shustik C, Kremer R, Rabbani SA, Hendy GN, Goltzman D. 1990. Circulating concentrations of parathyroid hormone-like peptide in malignancy and hyperparathyroidism. J Bone Miner Res 5:105-113.
23. Henderson JE, Amizuka N, Warshawsky H, Biasotto D, Lanske BMK, Goltzman D, Karaplis AC. 1995. Nucleolar targeting of PTHrP enhances survival of chondrocytes under conditions that promote cell death by apoptosis. Mol Cell Biol 15:4064-4075.
24. Henderson JE, Naski MC, Aarts M, Wang D, Cheng L, Goltzman D, Ornitz DM. 2000. Expression of FGFR3 with the G380R achondroplasia mutation inhibits proliferation and maturation of CFK2 chondrocytic cells. J Bone Miner Res 15:155-165.
25. Henderson J, Kremer R, Goltzman D. 2002. Systemic Factors in Skeletal Manifestations of Malignancy In: Bilezekian J, Raisz L, Rodan G, editors. Principles of Bone Biology. Second edition. New York: Academic Press, pp 1079-1092.
26. Horiuchi T, Yoshida T, Koshihara Y, Sakamoto H, Kanai H, Yamamoto S, Ito H. 1999. The increase of parathyroid hormone-related peptide and cytokine levels in synovial fluid of elderly rheumatoid arthritis and osteoarthritis. Endocrine J 46:643-649.
27. Hsu H, Shu HB, Pan MG, Goeddel DV. 1996. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84:299-308.
28. Huang SC, Tang MJ, Hsu KF, Cheng YM, Chou CY. 2002. Fas and its ligand, caspases, and bcl-2 expression in gonadotropin-releasing hormone agonist-treated uterine leiomyoma. J Clin Endocrinol Metab 87:4580-4586.
29. Karaplis AC, Luz A, Glowacki J, Bronson RT, Tybulewicz VLJ, Kronenberg HM, Mulligan RC. 1994. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide (PTHrP) gene. Genes Dev 8:277-289.
30. Kronenberg H. 2003. Developmental regulation of the growth plate. Nature 423 (May 2003):332-336.
31. Lam M, Olsen S, Rankin W, Ho P, Martin T, Gillespie M, Mosley J. 1997. PTHrP and cell division: Expression and localization of PTHrP in a keratinocyte cell line (HaCaT)) during the cell cycle. J Cell Physiol 173:433-446.
32. Lam MHC, House CM, Tiganis T, Mitchelhill KI, Sarcevic B, Cures A, Ramsay R, Kemp BE, Martin TJ, Gillespie MT. 1999. Phosphorylation at the cyclin-dependent kinase site (Thr85) of parathyroid hormone related protein negatively regulates its nuclear localization. J Biol Chem 274:18559-18566.
33. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. 1998. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94:481-490.
34. Malina HZ, Hess OM. 2004. Xanthurenic acid translocates proapoptptic Bcl-2 family proteins into mitochondria and impairs mitochondrial function. BMC Cell Function 5:1-7.
35. Massfelder T, Dann P, Wu TL, Vasavada R, Helwig JJ, Stewart AF. 1997. Opposing mitogenic and antimitogenic actions of parathyroid hormone-related protein in vascular smooth muscle cells: a critical role for nuclear targeting. Proc Natl Acad Sci (USA) 94:13630-13635.
36. Matsui T, Manabe N, Goto Y, Inoue N, Nishihara S, Miyamoto H. 2003. Expression and activity of Apaf1 and caspase-9 in granulosa cells during follicular atresia in pig ovaries. Reproduction 126:113-120.
37. Miao D, He B, Jiang Y, Kobayashi T, Soroceanu MA, Zhao J, Su H, Tong X, Amizuka N, Gupta A et al. 2005. Osteoblast derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34. J Clin Invest 115:2402-2411.
38. Mitchell C, Mignon A, Guidotti JE, Besnard S, Fabre M, Duverger N, Parlier D, Tedgui A, Kahn A, Gilgenkrantz H. 2000. Therapeutic liver repopulation in a mouse model of hypercholesterolemia. Hum Mol Genetics 9:1597-1602.
39. Nguyen MTA, He B, Chan G, Karaplis AC. 1997. Nucleolar translocation of PTHrP and its phosphorylation by CDC2 kinase. J Bone Miner Res 12:S210.
40. Nguyen M, He B, Karaplis A. 2001. Nuclear forms of parathyroid hormone related peptide are translated from non-AUG start sites downstream from the initiator methionine. Endocrinology 142:694-703.
41. Okano K, Tsukazaki T, Ohtsuru A, Osaki M, Yonekura A, Iwasaki K, Yamashita S. 1997. Expression of parathyroid hormone-related peptide in human osteoarthritis. J Orth Res 15:175-180.
42. Okoumassoun L, Averill-Bates D, Marion M, Denizeau F. 2003. Possible mechanisms underlying the mitogenic action of hepatchlor in rat hepatocytes. Toxicol Apllied Pharmacol 193:356-369.
43. Otsuki T, Tomokuni A, Sakaguchi H, Aikoh T, Matsuki T, Isozaki Y, Hyodoh F, Ueki H, Kusaka M, Kita S et al. 2000. Over-expression of the decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients. Clin Exptl Imm 119:323-327.
44. Peter ME, Krammer PH. 2003. The CD95(APO-1/Fas) DISC and beyond. Cell Death Diff 10:26-35.
45. Rozeman LB, Hameetman L, Cleton-Jansen AM, Taminiau AH, Hogendoorn PC, Bovee JV. 2005. Absence of IHH and retention of PTHrP signalling in endochondromas and central chondrosarcomas. J Pathology 205:476-482.
46. Segre GV. 1996. Receptors for parathyroid hormone and parathyroid hormone related protein. In: Bilezekian JP, Raisz LC, Rodan GA, editors. Principles of bone biology. New York: Academic Press, pp 377-403.
47. Sepulvida VAT, Shen X, Falzon M. 2002. Intracrine PTHrP protects against serum starvation-induced apoptosis and regulates the cell cycle in MCF-7 breast cancer cells. Endocrinology 143:596-606.
48. Shah S, Sylvester PW. 2004. Tocotrienol-induced caspase-8 activation is unrelated to death receptor apoptotic signaling in neoplastic mammary epithelial cells. Exp Biol Med 229:745-755.
49. Sharpe JC, Arnoult D, Youle RJ. 2004. Control of mitochondrial permeability by Bcl-2 family members. Biochim Biophys Acta 1644:107-113.
50. Shinoda S, Schindler CK, Quan-Lan J, Saugstad JA, Taki W, Simon RP, Henshall DC. 2003. Interaction of 14-3-3 with Bid during seizure-induced neuronal death. J Neurochem 86:460-469.
51. Sprick MR, Walczak H. 2004. The interplay between the Bcl-2 family and death receptor-mediated apoptosis. Biochim Biophys Acta 1644:125-132.
52. Tanel A, Averill-Bates DA. 2005. The aldehyde acrolein induces apoptosis via activation of the mitochondrial pathway. Biochim Biophys Acta 1743:255-267.
53. Terkeltaub R, Lotz M, Johnson K, Deng D, Hashimoto S, Goldring MB, Burton D, Deftos LJ. 1998. Parathyroid hormone related protein is abundant in osteoarthritic cartilage and the parathyroid hormone related protein 1-173 isoform is selectively induced by transforming growth factor b in articular chondrocytes and suppresses generation of extracellular inorganic pyrophosphate. Arthritis Rheumatism 41:2152-2164.
54. Thiede MA, Rodan GA. 1988. Expression of a calcium mobilizing parathyroid hormone-like peptide in lactating mammary tissue. Science 242:278-280.
55. Thiede B, Rudel T. 2004. Proteome analysis of apoptotic cells. Mass Spectrom Rev 23:333-349.
56. Thota CS, Reed LC, Yallampalli C. 2005. Effects of parathyroid hormone like hormone PTHLP antagonist, PTHLH (7-34) on fetoplacental development and growth during midgestation in rats. Biol Reproduction 73:1191-1198.
57. Tong QS, Zheng LD, Wang L, Liu J, Qian W. 2004. BAK overexpression mediates p53-independent apoptosis inducing effects on human gastric cancer cells. BMC Cancer 4:33-39.
58. Varfolomeev EE, Ashkenazi A. 2004. Tumor necrosis factor: An apoptosis JuNKie? Cell 116:491-497.
59. Wang D, Canaff L, Davidson D, Corluka A, Liu H, Hendy GN, Henderson JE. 2001. Alterations in the sensing and transport of phosphate and calcium by differentiating chondrocytes. J Biol Chem 276:33995-34005.
60. Weisleder N, Taffet GE, Capetanaki Y. 2004. Bcl-2 overexpression corrects mitochondrial defects and amelioratesinherited desmin null cardiomyopathy. Proc Natl Acad Sci USA 101:769-774.
61. Yoshikawa H, Nakajima Y, Tasaka K. 2001. IFN-gamma induces the apoptosis of WEHI 279 and normal pre-B cell lines by expressing direct inhibitor of apoptosis protein binding protein with low pI. J Immunol 2487-2495.